Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Developer Guides
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
Chad
WatchlistAccount

RVTY

Healthcare
Revvity, Inc. · Diagnostics & Research
Trades
23
Politicians
0
Buys
12
Sells
11
Trades
23
Politicians
0
Buys
12
Sells
11
RVTYvs S&P 500 (normalized)
|to
No price data available
RVTY S&P 500 Buy Sell
Range
PoliticianActionDescriptionAmountTradedFiled
Gilbert CisnerosD
SellRevvity, Inc. Common Stock [$15K - $50KSep 9, 2026Oct 12, 2026
Gilbert CisnerosD
SellRevvity, Inc. Common Stock [$1K - $15KSep 4, 2026Oct 12, 2026
Gilbert CisnerosD
SellRevvity, Inc. Common Stock$1K - $15KSep 3, 2026Oct 12, 2026
Ro KhannaD
SellREVVITY INC CMN$1K - $15KJun 30, 2026Jul 1, 2026
Gilbert CisnerosD
BuyRevvity, Inc. Common Stock [$15K - $50KMay 4, 2026Jun 8, 2026
Gilbert CisnerosD
BuyRevvity, Inc. Common Stock [$1K - $15KMay 1, 2026May 8, 2026
Gilbert CisnerosD
BuyRevvity, Inc. Common Stock$1K - $15KSep 12, 2025Oct 10, 2025
Ro KhannaD
SellREVVITY INC CMN$1K - $15KAug 26, 2025Sep 9, 2025
Gilbert CisnerosD
BuyRevvity, Inc. Common Stock$1K - $15KAug 13, 2025Sep 12, 2025
Gilbert CisnerosD
BuyRevvity, Inc. Common Stock$1K - $15KJul 23, 2025Aug 14, 2025
23 trades

Revvity, Inc. (RVTY) Congressional Stock Trades

This page tracks congressional stock trading activity in Revvity, Inc. (RVTY) in the Healthcare sector. Disclosed Capitol has indexed 23 disclosed congressional trades involving RVTY. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.

As of October 2026 — Disclosed Capitol has tracked 23 disclosed congressional trades in Revvity, Inc. (RVTY) — 12:11 buy-heavy ratio — led by Gilbert Cisneros (D).

Which members of Congress trade Revvity, Inc.?

  • Gilbert Cisneros (D) — 10 disclosed trades in RVTY
  • Ro Khanna (D) — 6 disclosed trades in RVTY
  • Lisa McClain (R) — 2 disclosed trades in RVTY
  • Rob Bresnahan (R) — 2 disclosed trades in RVTY
  • Byron Donalds (R) — 2 disclosed trades in RVTY

Recent RVTY congressional trades

DatePoliticianPartyActionAmount
Sep 9, 2026Gilbert CisnerosDSell$15,001 - $50,000
Sep 4, 2026Gilbert CisnerosDSell$1,001 - $15,000
Sep 3, 2026Gilbert CisnerosDSell$1,001 - $15,000
Jun 30, 2026Ro KhannaDSell$1,001 - $15,000
May 4, 2026Gilbert CisnerosDBuy$15,001 - $50,000
May 1, 2026Gilbert CisnerosDBuy$1,001 - $15,000
Sep 12, 2025Gilbert CisnerosDBuy$1,001 - $15,000
Aug 26, 2025Ro KhannaDSell$1,001 - $15,000
Aug 13, 2025Gilbert CisnerosDBuy$1,001 - $15,000
Jul 23, 2025Gilbert CisnerosDBuy$1,001 - $15,000

Buy vs. sell ratio & volume

Across the 23 disclosed congressional trades in Revvity, Inc. (RVTY), members of Congress have reported 12 buys and 11 sells. The average 30-day alpha vs. the S&P 500 is -3.35%.

Are Revvity, Inc. insiders buying or selling RVTY?

As of October 2026, corporate insiders at Revvity, Inc. have filed 9 SEC Form 4 transactions in RVTY over the past 12 months — including 4 sells worth $1.3M.

DateInsiderActionValue
2026-10-01Gonzales Anita — VP and CAOSale$13K
2026-09-21Krakowiak Maxwell — Please See RemarksSale$236K
2026-09-16Vohra Tajinder S — Please See RemarksSale$1.0M
2026-08-25MICHAS ALEXIS P — DirectorGift—
2026-08-14Goldberg Joel S — Please See RemarksGift—
2026-08-13Singh Prahlad R. — Please See RemarksGift—
2026-08-13Singh Prahlad R. — Please See RemarksGift—
2026-07-20Gonzales Anita — Vice President and CAOSale$9K
2026-06-15Gonzales Anita — Vice President and CAOTax Withholding$3K

Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.

Does Revvity, Inc. receive U.S. government contracts?

As of September 2026, Revvity, Inc. has 463 federal contract award records on file from USAspending.gov — most recently $2.0M from the Department of Health and Human Services on 2026-09-30.

Award dateAgencyAmount
2026-09-30Department of Health and Human Services · Office of the Assistant Secretary for Financial Resources$2.0M
2026-09-30Department of Health and Human Services · Office of the Assistant Secretary for Financial Resources$2.0M
2026-09-21Department of Health and Human Services · National Institutes of Health-$51K
2026-09-17Department of Veterans Affairs$10K
2026-09-17Department of Energy$68K
2026-09-11Department of Veterans Affairs$20K
2026-09-08Department of Health and Human Services · National Institutes of Health$44K
2026-09-02Department of Health and Human Services · National Institutes of Health$19K
2026-07-14Department of Homeland Security · Federal Emergency Management Agency$96K
2026-06-29Department of Health and Human Services · National Institutes of Health$97K

Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.

Revvity, Inc. financial snapshot (FY2025)

For fiscal year 2025, Revvity, Inc. reported revenue of $2.86B and net income of $241.2M, per SEC filings.

Revenue
$2.86B
Operating income
$356.6M
Net income
$241.2M
Diluted EPS
$2.07
Net margin
8.5%
Free cash flow
$509.4M

Most recent reported quarter: Q2 FY2026 — revenue $1.44B, net income $92.5M.

Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.